Physician profile
Steven E Mather
NPI 1346236163
$350,217.79
in general payments reported to CMS, 2019-2025
14 companies · $45K in 2025
The $45K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $70K · 2021: $47K · 2022: $70K · 2023: $60K · 2024: $59K · 2025: $45K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $158K · Consulting Fee: $4,750 · Food and Beverage: $755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $157,858.57 |
| Consulting Fee | $4,750.00 |
| Food and Beverage | $754.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinecraft, LLC | $348,290.60 | 2020-2025 | Astra Spine System, Aim, Orio |
| Globus Medical, INC. | $388.61 | 2019-2025 | Excelsius Gps, Alif, Elsa |
| Providence Medical Technology, INC. | $364.80 | 2019-2022 | |
| Cerapedics INC. | $197.98 | 2022 | |
| Depuy Synthes Sales INC. | $182.46 | 2019-2022 | |
| Centinel Spine, LLC | $164.78 | 2025 | Prodisc C Vivo |
| Amgen INC. | $131.59 | 2024 | Evenity |
| Medwest Associates | $117.00 | 2021 | |
| Nuvasive, INC. | $96.74 | 2022 | |
| Orthofix Medical, INC. | $88.82 | 2019-2021 | |
| Si-Bone, INC. | $78.28 | 2021 | |
| Medtronic, INC. | $55.19 | 2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Ebi, LLC | $31.53 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Medtronic USA, INC. | $29.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$24,153,396.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mather listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.